Which antiseizure (anticonvulsant) medications are used for migraine prophylaxis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 1, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Antiseizure Medications for Migraine Prophylaxis

For migraine prevention, use divalproex sodium (500-1500 mg/day) or sodium valproate (800-1500 mg/day) as first-line antiseizure medications, or topiramate as an alternative option. These are the only antiseizure medications with robust evidence supporting their use in migraine prophylaxis 1, 2, 3.

First-Line Antiseizure Medications

Valproate/Divalproex Sodium

  • Divalproex sodium: 500-1500 mg/day 1
  • Sodium valproate: 800-1500 mg/day 1
  • Classified as Level A evidence with strong recommendation for episodic migraine prevention 1, 2, 3
  • Particularly effective in patients with prolonged or atypical migraine aura 2
  • Critical warnings: Teratogenic effects including neural tube defects; absolutely avoid in women of childbearing potential unless using reliable contraception 2, 4
  • Common adverse effects: hair loss, tremor, weight gain, hepatotoxicity 2, 5
  • Often not prescribed as first choice due to weight gain and liver toxicity concerns 5

Topiramate

  • Dosing: Start low and titrate slowly (specific dosing not provided in guidelines, but typically 25-100 mg/day)
  • Strong evidence for both episodic and chronic migraine prevention 3, 6
  • Also effective for medication overuse headache 6
  • Critical warnings: Severe teratogenicity risk; requires education and contraception planning in women of childbearing potential 5
  • Common adverse effects: cognitive impairment, paresthesias, weight loss, kidney stones
  • Generally considered first choice among antiseizure medications when valproate is contraindicated 5

Antiseizure Medications NOT Recommended

The following antiseizure medications lack sufficient evidence or have been shown ineffective:

Weak Recommendation Against

  • Gabapentin: Weak recommendation against use for episodic migraine 3, 7

Insufficient Evidence (Do Not Use)

  • Levetiracetam: Insufficient evidence 3, 8, 9
  • Lamotrigine: Not effective 7
  • Vigabatrin: Not effective 7
  • Clonazepam: Not effective 7
  • Acetazolamide: Not effective 7
  • Carbamazepine: Insufficient evidence 5
  • Zonisamide: Only uncontrolled studies available 5, 8

Emerging Options (Limited Evidence)

  • Memantine: Weak recommendation for episodic migraine prevention 3, 9
  • May be considered as a later-line option when first-line agents fail

Clinical Implementation Algorithm

Step 1: Assess candidacy for preventive therapy

  • ≥2 attacks/month causing disability ≥3 days/month, OR
  • Contraindication/failure of acute treatments, OR
  • Using abortive medication >2 times/week, OR
  • Uncommon migraine conditions (hemiplegic, prolonged aura, migrainous infarction) 1

Step 2: Screen for contraindications

  • Women of childbearing potential: Avoid valproate and topiramate unless using reliable contraception 2, 4, 5
  • Liver disease: Avoid valproate 2
  • Kidney stones: Avoid topiramate
  • Cognitive concerns: Avoid topiramate

Step 3: Choose antiseizure medication

  • First choice: Topiramate (if no contraindications)
  • Alternative: Valproate/divalproex (if not childbearing potential and no liver disease)
  • Consider other drug classes first (propranolol, amitriptyline, CGRP inhibitors) as they may have better tolerability profiles 1, 4, 3

Step 4: Initiate and titrate

  • Start at low dose
  • Titrate slowly until clinical benefit achieved or limited by adverse effects
  • Allow 2-3 months for adequate trial before declaring treatment failure 1

Step 5: Monitor and adjust

  • Use headache diary to track frequency, severity, duration, and disability 1
  • Avoid medication overuse during preventive therapy 1
  • After period of stability, consider tapering or discontinuing 1, 4

Critical Pitfalls to Avoid

  1. Do not use gabapentin despite its common off-label use—evidence shows it is ineffective 3, 7
  2. Do not prescribe valproate to women of childbearing potential without explicit contraception counseling and documentation 2, 4, 5
  3. Do not abandon treatment prematurely—allow full 2-3 month trial before switching 1
  4. Do not use multiple antiseizure medications simultaneously without evidence of added benefit 4
  5. Do not assume all antiseizure medications work for migraine—only topiramate and valproate have proven efficacy 10, 5, 6

The evidence consistently shows that among antiseizure medications, only valproate and topiramate have Level A evidence for migraine prevention, while numerous other antiseizure medications commonly tried in practice lack supporting data 1, 2, 3, 7.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.